Seller record · plexusdx.com

PlexusDx

By Paul Harris, Standards EditorRecorded September 2026 · Standard v1.1 · How checks are performed

Fails 2 of 8 criteria. S3, pharmacy identification: No filling pharmacy is named. The product pages and answers say only a licensed 503A compounding pharmacy, and the footer says state-licensed compounding pharmacies operating in FDA-registered facilities. 1 more criterion also fails; see the table below.

At a glance

PlexusDxplexusdx.com

6/8criteria passed

Price: Semaglutide $189, tirzepatide $289 a month
Sells: compounded semaglutide injection and oral, and 8 more
FDA letters: None on file

Unpaid link. PlexusDx does not pay the site. Funding

Visit PlexusDx See all eight dispositions

Telehealth service. Passes 6 of 8 criteria. Recorded against Standard v1.1.

A genetic and blood testing company that also sells compounded semaglutide, tirzepatide and microdose GLP-1 plans, NAD+, sermorelin, GHK-Cu, glutathione and PT-141, each at one all-inclusive monthly price. It prints every price by plan length and names no filling pharmacy.

Operating entity PlexusDx, Inc.

Dispositions

Code	Criterion	Disposition	Where it appears
S1	Prescriber requirement	PASS	plexusdx.com/products/semaglutide-injection
S2	Prescription gating	PASS	intake.plexusdx.com
S3	Pharmacy identification	FAIL	plexusdx.com/products/semaglutide-injection, plexusdx.com/pages/faqs
S4	Compounding disclosure	PASS	plexusdx.com/products/semaglutide-injection, plexusdx.com/pages/faqs
S5	Analytical documentation	FAIL	plexusdx.com/pages/faqs, plexusdx.com/pages/about-us
S6	Business address	PASS	plexusdx.com/pages/terms-and-conditions, plexusdx.com/pages/privacy-policy
S7	Price disclosure	PASS	plexusdx.com/products/semaglutide-injection, plexusdx.com/products/tirzepatide-injection, plexusdx.com/products/microdose-glp1-protocol
S8	Enforcement status	PASS	FDA warning-letter index

Evidence, criterion by criterion

The evidence behind each disposition in the table above, where it appears, and its date.

S1PASSA licensed United States provider reviews each intake, selects the compound and writes the prescription, and nothing is charged until the provider approves it.Source: plexusdx.com/products/semaglutide-injection.

S2PASSEvery start button opens an intake form whose first question asks weight loss goals, the GLP-1 pages carry no cart button, and no charge is made before a provider approves the prescription.Source: intake.plexusdx.com.

S3FAILNo filling pharmacy is named. The product pages and answers say only a licensed 503A compounding pharmacy, and the footer says state-licensed compounding pharmacies operating in FDA-registered facilities.Source: plexusdx.com/products/semaglutide-injection, plexusdx.com/pages/faqs.

S4PASSCompounded medications are not FDA-approved or evaluated for safety, effectiveness, or quality, printed at the foot of every product page and repeated in the answers.Source: plexusdx.com/products/semaglutide-injection, plexusdx.com/pages/faqs.

S5FAILNo certificate of analysis or lot report is published for any compounded product, and the laboratory claims on the site concern its genetic and blood tests.Source: plexusdx.com/pages/faqs, plexusdx.com/pages/about-us.

S6PASSPlexusDx, Inc. at 6110 McFarland Station Drive, Unit 604, Alpharetta, GA 30004, printed in the footer, the terms and the privacy policy.Source: plexusdx.com/pages/terms-and-conditions, plexusdx.com/pages/privacy-policy.

S7PASSSemaglutide injection at $189 a month month to month, $169 on a three-month plan and $149 on a six-month plan, tirzepatide injection at $289, $269 and $249, microdose GLP-1 at a flat $129, and NAD+ and sermorelin from $129 a month.Source: plexusdx.com/products/semaglutide-injection, plexusdx.com/products/tirzepatide-injection, plexusdx.com/products/microdose-glp1-protocol.

S8PASSNo FDA warning letter names PlexusDx or PlexusDx, Inc., and no action has halted the business.Source: FDA warning-letter index.

Products shown on the seller's own pages at the recorded date: compounded semaglutide injection and oral, compounded tirzepatide injection and oral, microdose GLP-1, NAD+, sermorelin, GHK-Cu, glutathione, PT-141, genetic and blood tests.

Other sellers of the same products

Who sells semaglutide Who sells tirzepatide Who sells sermorelin Who sells NAD+Who sells glutathione Who sells PT-141 Who sells GHK-Cu

Unpaid link. PlexusDx does not pay the site, and nothing is earned when it is used. Funding.

Visit PlexusDx

Dispositions recorded against Standard v1.1. Method and null semantics: how checks are performed. This record is not a review and contains no medical advice.